Gene transfer as a strategy to achieve permanent cardioprotection II: rAAV-mediated gene therapy with heme oxygenase-1 limits infarct size 1 year later without adverse functional consequences

Bilirubin Possesses Powerful Immunomodulatory Activity and Suppresses Experimental Autoimmune Encephalomyelitis

(2014) Y. Liu et al.   JOURNAL OF IMMUNOLOGY

Remote ischemic preconditioning reduces myocardial injury after coronary artery bypass surgery with crystalloid cardioplegic arrest

(2010) Matthias Thielmann et al.   BASIC RESEARCH IN CARDIOLOGY

Adeno-associated virus: a key to the human genome?

(2010) Els Henckaerts et al.   Future Virology

Attenuation of myocardial injury by postconditioning: role of hypoxia inducible factor-1α

(2009) Huan-Xin Zhao et al.   BASIC RESEARCH IN CARDIOLOGY

HO-1 gene overexpression enhances the beneficial effects of superparamagnetic iron oxide labeled bone marrow stromal cells transplantation in swine hearts underwent ischemia/reperfusion: an MRI study

(2009) Yibo Jiang et al.   BASIC RESEARCH IN CARDIOLOGY

Gene Transfer of Inducible Nitric Oxide Synthase Affords Cardioprotection by Upregulating Heme Oxygenase-1 Via a Nuclear Factor-κB-Dependent Pathway

(2009) Qianhong Li et al.   CIRCULATION

AAV as a Gene Transfer Vector for the Treatment of Neurological Disorders: Novel Treatment Thoughts for ALS

(2009) Mark Hester et al.   CURRENT GENE THERAPY

Pleiotropic functions of biliverdin reductase: cellular signaling and generation of cytoprotective and cytotoxic bilirubin

(2009) Jaime Kapitulnik et al.   TRENDS IN PHARMACOLOGICAL SCIENCES

Cardioprotection

(2008) Gerd Heusch et al.   CIRCULATION

Pharmacological and Clinical Aspects of Heme Oxygenase

(2008) N. G. Abraham et al.   PHARMACOLOGICAL REVIEWS